NEUBASE THERAPEUTICS INC - COM (NBSE)

CUSIP: 64132K102

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COM
Total 13F shares
2,705,870
Share change
+489,011
Total reported value
$19,266,152
Price per share
$7.12
Number of holders
25
Value change
+$3,478,478
Number of buys
13
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 64132K102?
CUSIP 64132K102 identifies NBSE - NEUBASE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEUBASE THERAPEUTICS INC - COM (NBSE) as of Q1 2020

As of 31 Mar 2020, NEUBASE THERAPEUTICS INC - COM (NBSE) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,705,870 shares. The largest 10 holders included GREENLIGHT CAPITAL INC, RENAISSANCE TECHNOLOGIES LLC, ORBIMED ADVISORS LLC, EAM Investors, LLC, Squarepoint Ops LLC, BlackRock Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, PILLAR PACIFIC CAPITAL MANAGEMENT LLC, and JANE STREET GROUP, LLC. This page lists 25 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.